To validate the effect on cell migration, we performed a wound healing assay, where migration of HCC-4006 cells were examined upon treatment with CM obtained from HepG2 sh-con/sh-p53 cells that were pretreated with CM from HCC-4006. This evidence concerns the gene TP53 and hepatocellular carcinoma.